Clinical Trial

VB19055 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population

Name: VB19055 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population — clinical trial record (NCT07254481)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated November 28, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.

Summary

The purpose of this study is to evaluate the safety,tolerability,pharmacokinetics and pharmacodynamics of VB19055 in the healthy Chinese population.

Trial Details

NCT Number	NCT07254481
Lead Sponsor	Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
Conditions	Hypertension
Enrollment	86 participants
Start Date	2025-10-05
Primary Completion	2026-07 (estimated)
Study Completion	2026-07 (estimated)
Updated on ClinicalTrials.gov	2025-11-28